Somerset, NJ, United States of America

Carolina B Cabral

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Mersana Therapeutics, Inc.. Active years: 2013.

USPTO Granted Patents = 1 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 78(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Carolina B Cabral: Innovator in Polynucleotide Delivery Systems

Introduction

Carolina B Cabral is a prominent inventor based in Somerset, NJ (US). She has made significant contributions to the field of biotechnology, particularly in the development of modified polymers for the delivery of polynucleotides. Her innovative work has the potential to advance therapeutic methods in genetic medicine.

Latest Patents

Carolina holds a patent for "Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof." This patent describes a polynucleotide delivery vehicle that comprises a modified polymer. The modified polymer is designed to facilitate the delivery of polynucleotides to the cytoplasm of specific tissue types or cell types. Additionally, the patent outlines methods for reducing the expression of a gene in a cell or a subject in need thereof using the modified polymer.

Career Highlights

Carolina is currently employed at Mersana Therapeutics, Inc., where she continues to work on innovative solutions in the field of drug delivery. Her expertise in polymer chemistry and biotechnology has positioned her as a key player in her organization.

Collaborations

Carolina collaborates with talented professionals in her field, including Aleksandr V Yurkovetskiy and Mao Yin. These collaborations enhance her research and contribute to the advancement of their shared goals in biotechnology.

Conclusion

Carolina B Cabral is a trailblazer in the development of modified polymers for polynucleotide delivery, with a patent that showcases her innovative approach. Her work at Mersana Therapeutics, Inc. and collaborations with esteemed colleagues further highlight her impact in the biotechnology sector.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…